UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 21, 2017
Accession Number:
0001193125-17-206128
Submission Type:
POS AM
CIK:
0001533040
Company Name:
RXi Pharmaceuticals Corp
File Number:
333-203389